Literature DB >> 19299655

Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Haydar Frangoul, Tatsuki Koyama, Jennifer Domm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299655     DOI: 10.1182/blood-2008-09-177733

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation.

Authors:  Larisa Broglie; Caitrin Fretham; Amal Al-Seraihy; Biju George; Joanne Kurtzberg; Alison Loren; Margaret MacMillan; Caridad Martinez; Stella M Davies; Marcelo C Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2019-06-12       Impact factor: 5.742

2.  Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.

Authors:  Kenneth A Fowler; Corey M Jania; Stephen L Tilley; Angela Panoskaltsis-Mortari; Albert S Baldwin; Jonathan S Serody; James M Coghill
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.